TT-232

Tax included
TT-232 (CAP-232), a somatostatin derivative, is a peptide SSTR1/SSTR4 agonist. TT-232 inhibits cancer cell proliferation and induces apoptosis. TT-232 is also a broad-spectrum anti-inflammatory and analgesic agent.
MedChemExpress 
HY-105172

Data sheet

Size
Multiple sizes
Reactivity
Somatostatin Receptor
Application
COVID-19-immunoregulation
CAS
147159-51-1